Navigation Links
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014
Date:7/31/2014

5.5 million and $11.0 million in the second quarter and first half of 2013, respectively.

Net loss in the second quarter of 2014 was $32.6 million or $0.26 loss per share as compared to $42.7 million or $0.37 loss per share in the second quarter of 2013. Net loss in the first half of 2014 was $78.8 million or $0.63 loss per share as compared to $97.8 million or $0.85 loss per share in the first half of 2013.

The company also announced upcoming presentations at the following medical meetings and scientific congresses during the third and fourth quarters of 2014:

Global Cancer Conference 2014, Hyderabad, India:

  • Oral Abstract Title: "NKTR-214: A long-acting, engineered immunotherapy shows excellent therapeutic efficacy in multiple syngeneic mouse tumor models both alone and in combination with checkpoint inhibition", Addepalli, M., et al. 
  • Date: September 15-17, 2014
  • IASP 15th World Congress on Pain, Buenos Aires, Argentina:

  • Abstract/Poster Title: "Multi-dimensional pathway analysis reveals unique pharmacological signatures of kappa opioid receptor agonists", Brew, C., et al. 
  • Date: October 10, 2014, 9:30 a.m. Argentina Time
  • Society for Neuroscience, Washington, DC:

  • Abstract/Poster Title: "SEO-16: An orally active opioid analgesic with rapid onset of activity and reduced CNS side effects", Harrison, S., et al. 
  • Poster Session 244: "Opioids and other analgesics"
  • Date: November 16, 2014, 1:00 p.m. — 5:00 p.m. Eastern Time
  • Conference Call to Discuss Second Quarter 2014 Financial ResultsNektar management will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time today, Thursday, July 31, 2014.

    This press release and a live audio-only Webcast of the conference call can be accessed through a link that is posted on the home
    '/>"/>

    SOURCE Nektar Therapeutics
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets
    2. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
    3. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
    4. Nektar to Announce Financial Results for the Third Quarter of 2013 on Thursday, November 7, 2013, After Close of U.S.-Based Financial Markets
    5. Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol
    6. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013
    7. Nektar to Announce Financial Results for the Second Quarter of 2013 on Thursday, August 8, 2013, After Close of U.S.-Based Financial Markets
    8. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
    9. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
    10. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
    11. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/21/2014)... Nov. 20, 2014  The acceptance of two ... AAGL Global Congress demonstrates continued interest in the ... provide bowel control. One of the abstracts, presented by ... Division Chief of Urogynecology and Reconstructive Pelvic Surgery ... Award for Best Written Abstract on Urogynecology/Pelvic Floor ...
    (Date:11/21/2014)... Calif. , Nov. 20, 2014 Depomed, Inc. (NASDAQ: ... at the Piper Jaffray 26 th Annual Healthcare Conference in ... at the Piper Jaffray conference is scheduled for 8:00 am EST ... be webcast, and the webcast can be accessed via the Investor ... recording of the webcast will be archived for 30 days on ...
    (Date:11/21/2014)... 20, 2014 Oxis International, Inc. (OXIS) (OXI.PA) announced ... of Anthony J. Cataldo as Chief Executive Officer, ... November 19, 2014, Ken Eaton resigned his positions ... Directors of Oxis International, Inc. to pursue new opportunities. ... Chief Executive Officer of Oxis International, Inc. Mr. Cataldo will ...
    Breaking Medicine Technology:LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 3Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference 2OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3
    ... 14, 2007 - BioDelivery,Sciences International, Inc. (Nasdaq: ... Fentanyl in cancer,patients with breakthrough pain in ... product., Results were based on the company's ... the study. A key secondary,endpoint was the ...
    ... market dynamics offers insights into,what will be needed ... to,patients, NEW YORK, May 14, 2007 /PRNewswire-USNewsire/ -- ... a not-for-profit,product development partnership accelerating the discovery and,development ... the first,comprehensive study of the dynamics of the ...
    Cached Medicine Technology:BDSI Announces Positive Key Secondary Efficacy Endpoint Results for,Bema Fentanyl 2BDSI Announces Positive Key Secondary Efficacy Endpoint Results for,Bema Fentanyl 3BDSI Announces Positive Key Secondary Efficacy Endpoint Results for,Bema Fentanyl 4New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace 2New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace 3New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace 4
    (Date:11/21/2014)... Grants Pass, OR (PRWEB) November 21, 2014 ... and become thirsty. In winter, people rarely perspire and ... felt in winter to drink the eight glasses of ... Don’t be fooled, warns fresh water advocate Sharon Kleyne. ... and maintaining daily hydration is just as important.     ...
    (Date:11/21/2014)... For many busy people, having their missing or ... of recovery from dental surgery that have traditionally been required ... of their youthful appearance. , But the dental implant ... and Woodland Hills, Calif., can provide someone with a full ... where the patient’s bone has deteriorated. , Dr. Saj Jivraj ...
    (Date:11/21/2014)... (PRWEB) November 21, 2014 CDT ... the dental practice. It includes everything needed to process ... Procedure Coding with CDT , CDT 2015 codes are ... January 1, 2014 - December 31, 2014. Dental professionals ... and services on dental claims. There are significant changes ...
    (Date:11/21/2014)... November 21, 2014 Even with years of ... to learn and room for growth, participating in two recent ... State Farm’s National Convention, a networking event with the leaders ... country, bringing back the latest and greatest in insurance news ... spotted Kirk and his team (Stacy, Anthony, Reina and Jacob) ...
    (Date:11/21/2014)... November 21, 2014 CARE Surrogacy Center ... intended parents — and at the same time enhancing their ... of optimism for future parents across the globe, the company ... Prospective parents today are zoning in on the skyrocketing costs ... encumbering costs, are individuals over-stressing clinical success rates ? ...
    Breaking Medicine News(10 mins):Health News:Our Bodies Need Eight Glasses of Water a Day Even in Winter Reports Fresh Water Advocate 2Health News:Our Bodies Need Eight Glasses of Water a Day Even in Winter Reports Fresh Water Advocate 3Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 2Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 3Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 4Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 5Health News:PMIC Announces CDT PLUS! 2015, the Ultimate Coding Reference for Dentists and Oral Surgeons 2Health News:Kirk Martin Insurance Agency Goes Local and National with State Farm 2Health News:CARE Surrogacy Center Reports on its Multiple Measures of Success 2Health News:CARE Surrogacy Center Reports on its Multiple Measures of Success 3
    ... energy sources to the eye may help delay retinal ... The transporters, SMCT1 and SMCT2, can circumvent the eyes ... bodies to a healthy eye, says Dr. Pamela Martin, ... diabetes, characterized by plenty of glucose but the inability ...
    ... Study supports effectiveness of the ultrasound-guided technique , ... minimally invasive procedure is a quick, inexpensive way ... report. , The researchers used ultrasound-guided percutaneous (through ... more than 2,000 people (average age 42) with ...
    ... Using a novel imaging technique to study autistic ... brain areas that govern social processing and learning by ... J. Lindner Center for Autism, North Shore-Long Island Jewish ... the annual meeting of the Radiological Society of North ...
    ... 28, 2007 (Oakland, CA) The National Heart ... over the next five years to establish a ... will leverage the collective cardiovascular expertise, diverse community-based ... Kaiser Permanente and eight other health plans in ...
    ... Card System to Revolutionize Adult Sexual Behaviors, ... Inc.,(SSPB) announced today it will launch the world,s ... Safe Sex Passport (SSP) on December,1st, in conjunction ... the,spread of Sexually Transmitted Diseases (STDs) by providing ...
    ... pleased to,announce that Gail Oliver has been named Vice ... this position, Ms. Oliver will lead,and manage the Loss ... development opportunities for this aspect of the,company,s portfolio., ... years. Most recently, she,has been serving as the Regional ...
    Cached Medicine News:Health News:Transporters may help delay diabetes-related retinal damage 2Health News:Transporters may help delay diabetes-related retinal damage 3Health News:Saline Wash May Ease Shoulder Tendonitis 2Health News:Novel imaging technique shows gray matter increase in brains of autistic children 2Health News:National Heart Lung and Blood Institute creates national network to study cardiovascular disease 2Health News:Safe Sex Passport Launches to Provide Breakthrough Protection Against STDs and HIV 2
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    Medicine Products: